Passionately committed to applying our leadership in cellular metabolism to transform the lives of people with genetically defined diseases" title="" class="btn" data-container="body" data-html="true" data-id="40176" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Agios"> 2,610 83,487
Activities
Technologies
Entity types
Location
88 Sidney St, Cambridge, MA 02139, USA
Cambridge
United States of America
Employees
Scale: 201-500
Estimated: 597
Engaged corporates
9Added in Motherbase
5 years, 9 months agoWhere science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases.
Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies.
We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results.
Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias
Over the 12+ years Agios has been in existence, we have remained committed to patients first and to following the science. Our legacy is rooted in a powerful set of strengths, values and competencies. We have built on our core differentiators to make a positive difference for patients through truly differentiated therapies. This foundation will remain constant at Agios and accelerate our impact moving forward.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() EU Green Capital European Union, Environmental Services | EU Green Capital European Union, Environmental Services | Other 18 Dec 2024 | | |
![]() Pharma IQ Pharmaceutical, Pharmaceutical Manufacturing | Pharma IQ Pharmaceutical, Pharmaceutical Manufacturing | Other 31 May 2023 | | |
![]() Illumina For Startups Startup accelerator & VC, Biotechnology, Biotechnology Research | Illumina For Startups Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 20 Sep 2019 | | |
![]() Incyte Pharmaceutical, Pharmaceutical Manufacturing | Incyte Pharmaceutical, Pharmaceutical Manufacturing | Other 8 Mar 2022 | | |
![]() Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Apr 2018 | | |
![]() Nasdaq Finance, Financial Services | Nasdaq Finance, Financial Services | Not capitalistic Not partnership Event 13 Aug 2018 | | |
![]() Boston Consulting Group (BCG) Consulting, Business Consulting and Services | Boston Consulting Group (BCG) Consulting, Business Consulting and Services | Not capitalistic Partnership Event 24 Jul 2020 | | |
![]() Vertex Pharmaceuticals Biotechnology, Biotechnology Research | Vertex Pharmaceuticals Biotechnology, Biotechnology Research | Not capitalistic Partnership Event 23 Feb 2021 | | |
![]() Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Not event 21 Dec 2020 17 Mar 2023 | | |